Public Employees Retirement System of Ohio decreased its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 4.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 152,767 shares of the financial services provider's stock after selling 7,563 shares during the quarter. Public Employees Retirement System of Ohio's holdings in CME Group were worth $35,477,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in CME. New Age Alpha Advisors LLC lifted its stake in shares of CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after purchasing an additional 43 shares during the last quarter. Avidian Wealth Enterprises LLC raised its holdings in CME Group by 2.6% in the fourth quarter. Avidian Wealth Enterprises LLC now owns 1,769 shares of the financial services provider's stock worth $411,000 after purchasing an additional 45 shares in the last quarter. TFC Financial Management Inc. lifted its position in shares of CME Group by 8.4% during the fourth quarter. TFC Financial Management Inc. now owns 592 shares of the financial services provider's stock valued at $137,000 after buying an additional 46 shares during the last quarter. Waldron Private Wealth LLC lifted its position in shares of CME Group by 2.0% during the fourth quarter. Waldron Private Wealth LLC now owns 2,362 shares of the financial services provider's stock valued at $549,000 after buying an additional 47 shares during the last quarter. Finally, Venturi Wealth Management LLC boosted its holdings in shares of CME Group by 12.1% in the 4th quarter. Venturi Wealth Management LLC now owns 437 shares of the financial services provider's stock valued at $101,000 after buying an additional 47 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company's stock.
CME Group Stock Up 0.6%
Shares of CME stock traded up $1.62 on Wednesday, reaching $285.98. 2,295,687 shares of the stock were exchanged, compared to its average volume of 2,190,500. The company has a market capitalization of $103.06 billion, a price-to-earnings ratio of 29.57, a PEG ratio of 6.76 and a beta of 0.45. The business's 50 day moving average price is $268.56 and its 200 day moving average price is $250.00. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $287.04.
CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.61 by $0.19. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The business had revenue of $1.64 billion during the quarter, compared to analysts' expectations of $1.56 billion. During the same period in the prior year, the firm posted $2.50 EPS. The business's quarterly revenue was up 10.4% compared to the same quarter last year. As a group, sell-side analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be paid a $1.25 dividend. The ex-dividend date of this dividend is Monday, June 9th. This represents a $5.00 annualized dividend and a yield of 1.75%. CME Group's dividend payout ratio is currently 50.30%.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently issued reports on the company. Bank of America upped their price target on CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research report on Wednesday, April 2nd. Oppenheimer boosted their price objective on CME Group from $269.00 to $279.00 and gave the company an "outperform" rating in a report on Friday, April 11th. Piper Sandler raised their price target on shares of CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a research report on Tuesday, April 8th. JPMorgan Chase & Co. dropped their price objective on CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a report on Thursday, April 24th. Finally, Raymond James raised shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price target on the stock in a research note on Monday, March 10th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $256.80.
Check Out Our Latest Report on CME
Insiders Place Their Bets
In other CME Group news, insider Hilda Harris Piell sold 3,984 shares of the business's stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $250.47, for a total value of $997,872.48. Following the completion of the sale, the insider now owns 27,046 shares in the company, valued at approximately $6,774,211.62. The trade was a 12.84% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Howard J. Siegel sold 10,000 shares of the stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $260.00, for a total value of $2,600,000.00. Following the completion of the sale, the director now directly owns 21,873 shares of the company's stock, valued at $5,686,980. The trade was a 31.37% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 28,384 shares of company stock valued at $7,531,053. 0.30% of the stock is owned by corporate insiders.
CME Group Company Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.